Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 18/20 | 0.50 |
| ▸ | ITGB1 | P05556 | 17/20 | 0.50 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.50 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6807468 | 0.94 | ITGB1 (0.54) | ITGA4ITGB1ITGA2ITGB7 | |
| SCHEMBL6807443 | 0.91 | ITGB1 (0.50) | ITGA4ITGB1ITGA2ITGB7OPRK1 | |
| SCHEMBL6812370 | 0.89 | PLD1 (0.47) | ITGA4ITGB1ITGB7OPRK1OPRM1 | |
| SCHEMBL5782643 | 0.85 | OPRK1 (0.52) | ITGA4ITGB1OPRK1OPRM1OPRD1 | |
| SCHEMBL6812470 | 0.84 | ITGB1 (0.50) | ITGA4ITGB1ITGA2ITGB7OPRK1 | |
| SCHEMBL5782560 | 0.83 | OPRK1 (0.53) | OPRK1OPRM1OPRD1OPRL1 | |
| SCHEMBL6807923 | 0.83 | CTSB (0.48) | ITGA4ITGB1OPRK1 | |
| SCHEMBL5783259 | 0.82 | OPRK1 (0.52) | ITGA4ITGB1OPRK1OPRM1OPRD1 | |
| SCHEMBL13602001 | 0.80 | ITGB1 (0.66) | ITGA4ITGB1ITGB7OPRK1OPRM1 | |
| SCHEMBL21688404 | 0.78 | OPRK1 (0.57) | OPRK1OPRM1OPRD1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | TORAY INDUSTRIES, INC. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-1323709-A1 | UREA DERIVATIVE AND ADHESIVE-MOLECULE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2003-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | ICAM1, VCAM1, EPCAM | ITGA4 221/4885ITGB1 55/4885ITGA2 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.